1945
Established in Iba-cho, Toyama Prefecture as an evacuation plant for Santendo Pharmaceutical Co.
1947
Mita Seiyaku Co., Ltd. established as an independent company from Santendo Pharmaceutical Co.
Manufacture and sale of household medicine for placement
1967
Entered the field of ethical pharmaceuticals
1971
Company name changed to Toyo Falmer Co.
1995
Head office relocated to Kanazawa City, Ishikawa Prefecture
2005
Capital alliance with KYORIN Pharmaceutical Co.
2006
Transitioned to a wholly owned subsidiary of KYORIN Pharmaceutical Holdings Co.
2007
Company name changed to KYORIN Rimedio Co.
New laboratory and welfare building added at Iba Plant
2010
Integration of logistics with KYORIN Pharmaceutical Co.
2016
First authorized generic (montelukast tablets) is launched.
2017
Takaoka Drug Research Institute established.
2018
Transferred Iba Plant to KYORIN Group Plant Co.
2019
Authorized generic (mometasone nasal spray) launched.
Year 2020
Launched Authorized Generic (imidafenacin tablets and OD tablets)
Mita Seiyaku Co., Ltd. established (1947)
Company name changed to Toyo Falmer Corporation (1971)
Moved to Kanazawa City (1995)
Takaoka Drug Discovery Research Institute established (2017)